Skip to main content

Krazati Prices, Coupons, Copay Cards & Patient Assistance

Krazati (adagrasib) is a member of the miscellaneous antineoplastics drug class and is commonly used for Colorectal Cancer, and Non Small Cell Lung Cancer.

The cost for Krazati 200 mg oral tablet is around $24,128 for a supply of 180 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Krazati is available as a brand name drug only, a generic version is not yet available. View generic Krazati availability for more details.

Krazati prices

Oral Tablet

200 mg

Krazati oral tablet

 from $24,127.67

for 180 tablets
Quantity Per unit Price
180 $134.04 $24,127.67

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Krazati Coupons, Copay Cards and Rebates

Krazati offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Krazati Mirati & Me Financial Support

Eligible commercially patients pay as little as $0 per prescription.

Applies to:
Krazati
Number of uses:
Per prescription until program expires

Form more information phone: 844-647-2842 or Visit website

Krazati Mirati & Me Free Trial Offer

Eligible patients may recevie a free 30-day supply of medication; this is a one-time offer per patient per lifetime.

Applies to:
Krazati
Number of uses:
One-time offer

Form more information phone: 844-647-2842 or Visit website

Krazati Mirati & Me Bridge Program

Eligible commercially insured patients experiencing a lapse in insurance coverage may be able to receive financial assistance for an appropriate supply of medication.

Applies to:
Krazati
Number of uses:
Temporary Assistance

Form more information phone: 844-647-2842 or Visit website

Krazati Mirati & Me Quick Start Program

Eligible commercially insured patients experiencing a delay in insurance coverage may be able to receive financial assistance for an appropriate supply of medication.

Applies to:
Krazati
Number of uses:
Temporary Assistance

Form more information phone: 844-647-2842 or Visit website

Patient Assistance & Copay Programs for Krazati

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Krazati (adagrasib) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: Bristol Myers Squibb (BMS) Access Support

Eligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or Puerto Rico
  5. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please refer to the Enrollment Form to ensure the correct Fax number and address is used for your medication.
Applicable drugs:
  • Krazati (adagrasib) Tablet

More information please phone: 800-861-0048 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.